The project team will analyze the market opportunity for a novel NGS library preparation kit for Illumina NGS systems that, in addition to primary sequence, captures long-range information enabling large structural variant detection and haplotype phasing along with 3D chromatin architecture.
Survey of disease indications for a comparative biology-based drug discovery platform
February 06, 2020
The BCBA project team will conduct a survey to evaluate and prioritize cardiovascular, metabolic, and neuro indications for an early stage company’s target discovery platform that leverages the power of comparative biology to develop therapeutics.
Prioritization of ocular indications for a novel gene editing platform
February 06, 2020
The multi-institutional project team will conduct a survey to evaluate and prioritize ocular indications for a venture-backed company’s novel gene editing platform.
Patent application writing for a first-in-class anti-inflammatory compound
November 21, 2019
Lupa Bio is a start-up company founded to advance evolutionary biology with an aim to disrupt the prescription anti-inflammatory market. They are an innovative, Indie Bio-funded company with a founding team
Prioritization of oncology targets for novel medicinal chemistry approach
November 5, 2019
The multi-institutional project team will analyze and prioritize oncology targets for drug development by an early stage, venture-backed company with an innovative medicinal chemistry platform
Market opportunity assessment for a novel stem cell-based drug discovery platform
September 6, 2019
The multi-institutional project team will evaluate the drug discovery landscape to prioritize market entry points for a versatile human stem cell-based technology platform that can be used in preclinical testing